Vaccinex, Inc. Unrealized Gain (Loss) on Derivatives
Vaccinex, Inc. (VCNX) reported Unrealized Gain (Loss) on Derivatives of -$95.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2025-04-15
- Vaccinex, Inc. unrealized gain (loss) on derivatives for the quarter ending 2024-12-31 was -$14.00K.
- Vaccinex, Inc. unrealized gain (loss) on derivatives for the quarter ending 2024-09-30 was $0.00.
- Vaccinex, Inc. unrealized gain (loss) on derivatives for the quarter ending 2024-06-30 was -$81.00K.
- Vaccinex, Inc. unrealized gain (loss) on derivatives for the quarter ending 2024-03-31 was $0.00.
- Vaccinex, Inc. unrealized gain (loss) on derivatives for fiscal 2024 was -$95.00K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$14.00K derived: sum of 2 quarters · filed 2025-04-15 | -$95.00K derived: sum of 3 quarters · filed 2025-04-15 | -$95.00K 10-K · filed 2025-04-15 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | -$81.00K derived: sum of 2 quarters · filed 2024-11-14 | -$81.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$81.00K 10-Q · filed 2024-08-14 | -$81.00K 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2025-04-15 |